-
-
-
-
-
-
-
Assertio Therapeutics (ASRT) Tops Q2 EPS by 10c
-
-
-
-
-
-
-
Assertio Therapeutics (ASRT) Tops Q4 EPS by 1c ; Offers Guidance
-
-
-
-
-
-
-
Assertio Holdings (ASRT) Issues Response to Letter from Short-seller
-
-
-
-
-
-
-
Assertio Therapeutics (ASRT) Tops Q1 EPS by 4c, provides guidance
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Assertio
-
-
-
-
-
-
-
ASSERTIO HOLDINGS, INC. (NASDAQ: ASRT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Assertio Ho
-
-
-
-
-
-
-
ASSERTIO HOLDINGS, INC. (NASDAQ: ASRT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Assertio Ho
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

